Patents by Inventor Kensaku Nakayama

Kensaku Nakayama has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20180104263
    Abstract: Butyrylcholinesterase inhibitors, their formulation, and their use primarily in the treatment of neurodegenerative diseases. These inhibitors generally are phosphates, phosphonates, phosphinates, and phosphoramidates. These inhibitors can be incorporated in pharmaceutical compositions and administered to a patient in therapeutically effective amounts to treat neurodegenerative diseases.
    Type: Application
    Filed: September 8, 2017
    Publication date: April 19, 2018
    Inventors: Roger A. Acey, Kensaku Nakayama
  • Patent number: 9757399
    Abstract: Butyrylcholinesterase inhibitors, their formulation, and their use primarily in the treatment of neurodegenerative diseases. These inhibitors generally are phosphates, phosphonates, phosphinates, and phosphoramidates. These inhibitors can be incorporated in pharmaceutical compositions and administered to a patient in therapeutically effective amounts to treat neurodegenerative diseases.
    Type: Grant
    Filed: January 22, 2016
    Date of Patent: September 12, 2017
    Assignee: JAL THERAPEUTICS, INC.
    Inventors: Roger A. Acey, Kensaku Nakayama
  • Publication number: 20160206635
    Abstract: Butyrylcholinesterase inhibitors, their formulation, and their use primarily in the treatment of neurodegenerative diseases. These inhibitors generally are phosphates, phosphonates, phosphinates, and phosphoramidates. These inhibitors can be incorporated in pharmaceutical compositions and administered to a patient in therapeutically effective amounts to treat neurodegenerative diseases.
    Type: Application
    Filed: January 22, 2016
    Publication date: July 21, 2016
    Inventors: Roger A. Acey, Kensaku Nakayama
  • Publication number: 20140073608
    Abstract: Butyrylcholinesterase inhibitors, their formulation, and their use primarily in the treatment of neurodegenerative diseases. These inhibitors generally are phosphates, phosphonates, phosphinates, and phosphoramidates. These inhibitors can be incorporated in pharmaceutical compositions and administered to a patient in therapeutically effective amounts to treat neurodegenerative diseases.
    Type: Application
    Filed: November 5, 2013
    Publication date: March 13, 2014
    Applicant: MGP Biotechnologies, LLC
    Inventors: Roger A. Acey, Kensaku Nakayama
  • Publication number: 20100069337
    Abstract: Butyrylcholinesterase inhibitors, their formulation, and their use primarily in the treatment of neurodegenerative diseases. These inhibitors generally are phosphates, phosphonates, phosphinates, and phosphoramidates. These inhibitors can be incorporated in pharmaceutical compositions and administered to a patient in therapeutically effective amounts to treat neurodegenerative diseases.
    Type: Application
    Filed: October 31, 2007
    Publication date: March 18, 2010
    Inventors: Roger A. Acey, Kensaku Nakayama